Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Apr 2;93(7):2953–2957. doi: 10.1073/pnas.93.7.2953

Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer.

M F Kozacko 1, T S Mang 1, A V Schally 1, R L Priore 1, C Liebow 1
PMCID: PMC39741  PMID: 8610149

Abstract

We previously reported that CO2 laser incisions in carcinogen-initiated fields promoted cancer development and caused release of growth factors. Here we examined the quantitative and additive properties of this tumor-promoting event and examined whether this promotion could be nullified by treatment with a bombesin antagonist, which down-regulates epidermal growth factor receptors. The model used for cancer promotion was the hamster buccal cheek pouch that had been treated with a carcinogen (9,10-dimethyl-1,2-benzanthracene) for 6 weeks, producing premalignant lesions. These lesions would evolve into a cancer eventually without further treatment. Promotion was measured both by increased fluorescence in response to systemically administered Photofrin, measured noninvasively using an in vivo fluorescence photometer, and by the timing of appearance of clinical tumors. Laser incisions (0-3) were made into the hamster cheek 1 week apart, or three incisions were done 1 day apart. Another group of animals received bombesin antagonist RC-3095 for 4 weeks during the time incisions were made, again measuring promotion. Laser incisions 1 week apart produced additive promotion, whereas three incisions 1 day apart were not statistically different from the group receiving only one incision. RC-3095 treatment completely eliminated the promoting effects of incision and totally stopped promotion for the 4-week period of treatment. After discontinuing treatment with RC-3095, lesion progression resumed at the untreated control rate. This work confirms that the promoting event of a laser incision follows a comparable time course to release of growth factors after such an incision and that it can be eliminated by treatment with bombesin antagonists.

Full text

PDF
2953

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARONS M. S., LYNCH J. B., LEWIS S. R., BLOCKER T. G., Jr SCAR TISSUE CARCINOMA. I. A CLINICAL STUDY WITH SPECIAL REFERENCE TO BURN SCAR CARCINOMA. Ann Surg. 1965 Feb;161:170–188. doi: 10.1097/00000658-196502000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ames B. N., Gold L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990 Aug 31;249(4972):970–971. doi: 10.1126/science.2136249. [DOI] [PubMed] [Google Scholar]
  3. Balchum O. J., Profio A. E., Razum N. Ratioing fluorometer probe for localizing carcinoma in situ in bronchi of the lung. Photochem Photobiol. 1987 Nov;46(5):887–891. doi: 10.1111/j.1751-1097.1987.tb04864.x. [DOI] [PubMed] [Google Scholar]
  4. Battey J. F., Way J. M., Corjay M. H., Shapira H., Kusano K., Harkins R., Wu J. M., Slattery T., Mann E., Feldman R. I. Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):395–399. doi: 10.1073/pnas.88.2.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bishop J. M. The molecular genetics of cancer. Science. 1987 Jan 16;235(4786):305–311. doi: 10.1126/science.3541204. [DOI] [PubMed] [Google Scholar]
  6. Carney D. N., Cuttitta F., Moody T. W., Minna J. D. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res. 1987 Feb 1;47(3):821–825. [PubMed] [Google Scholar]
  7. Carpenter G., Cohen S. Epidermal growth factor. J Biol Chem. 1990 May 15;265(14):7709–7712. [PubMed] [Google Scholar]
  8. Cohen S., Ushiro H., Stoscheck C., Chinkers M. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem. 1982 Feb 10;257(3):1523–1531. [PubMed] [Google Scholar]
  9. Crean D. H., Liebow C., Penetrante R. B., Mang T. S. Evaluation of porfimer sodium fluorescence for measuring tissue transformation. Cancer. 1993 Nov 15;72(10):3068–3077. doi: 10.1002/1097-0142(19931115)72:10<3068::aid-cncr2820721032>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  10. Cuttitta F., Carney D. N., Mulshine J., Moody T. W., Fedorko J., Fischler A., Minna J. D. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. 1985 Aug 29-Sep 4Nature. 316(6031):823–826. doi: 10.1038/316823a0. [DOI] [PubMed] [Google Scholar]
  11. Di Fiore P. P., Segatto O., Taylor W. G., Aaronson S. A., Pierce J. H. EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science. 1990 Apr 6;248(4951):79–83. doi: 10.1126/science.2181668. [DOI] [PubMed] [Google Scholar]
  12. Edwards M. J., Hirsch R. M., Broadwater J. R., Netscher D. T., Ames F. C. Squamous cell carcinoma arising in previously burned or irradiated skin. Arch Surg. 1989 Jan;124(1):115–117. doi: 10.1001/archsurg.1989.01410010125024. [DOI] [PubMed] [Google Scholar]
  13. GARDNER A. W. Trauma and squamous skin cancer. Lancet. 1959 Apr 11;1(7076):760–761. doi: 10.1016/s0140-6736(59)91831-8. [DOI] [PubMed] [Google Scholar]
  14. Homburger F. Mechanical irritation, polycyclic hydrocarbons, and snuff. Effects on facial skin, cheek pouch, and oral mucosa in Syrian hamsters. Arch Pathol. 1971 May;91(5):411–417. [PubMed] [Google Scholar]
  15. Hunter T. Cooperation between oncogenes. Cell. 1991 Jan 25;64(2):249–270. doi: 10.1016/0092-8674(91)90637-e. [DOI] [PubMed] [Google Scholar]
  16. Johansson S., Andersson N., Andersson G. Pretranslational and posttranslational regulation of the EGF receptor during the prereplicative phase of liver regeneration. Hepatology. 1990 Sep;12(3 Pt 1):533–541. doi: 10.1002/hep.1840120314. [DOI] [PubMed] [Google Scholar]
  17. Kitazawa T., Kinoshita S., Fujita K., Araki K., Watanabe H., Ohashi Y., Manabe R. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor. Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1773–1778. [PubMed] [Google Scholar]
  18. Liebow C., Crean D. H., Lee M. T., Kamer A. R., Mang T. S., Schally A. V. Synergistic effects of bombesin and epidermal growth factor on cancers. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3804–3808. doi: 10.1073/pnas.91.9.3804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liebow C., Crean D. H., Schally A. V., Mang T. S. Peptide analogues alter the progression of premalignant lesions, as measured by Photofrin fluorescence. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1897–1901. doi: 10.1073/pnas.90.5.1897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mahmoud S., Palaszynski E., Fiskum G., Coy D. H., Moody T. W. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues. Life Sci. 1989;44(5):367–373. doi: 10.1016/0024-3205(89)90231-2. [DOI] [PubMed] [Google Scholar]
  21. Mang T. S., McGinnis C., Liebow C., Nseyo U. O., Crean D. H., Dougherty T. J. Fluorescence detection of tumors. Early diagnosis of microscopic lesions in preclinical studies. Cancer. 1993 Jan 1;71(1):269–276. doi: 10.1002/1097-0142(19930101)71:1<269::aid-cncr2820710141>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  22. Noguchi S., Ohba Y., Oka T. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinol. 1991 Mar;128(3):425–431. doi: 10.1677/joe.0.1280425. [DOI] [PubMed] [Google Scholar]
  23. Preston S. R., Woodhouse L. F., Jones-Blackett S., Wyatt J. I., Primrose J. N. High affinity binding sites for gastrin releasing peptide on human gastric cancer and Ménétrier's mucosa. Cancer Res. 1993 Nov 1;53(21):5090–5092. [PubMed] [Google Scholar]
  24. Qin Y., Ertl T., Cai R. Z., Halmos G., Schally A. V. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res. 1994 Feb 15;54(4):1035–1041. [PubMed] [Google Scholar]
  25. Radulovic S., Schally A. V., Reile H., Halmos G., Szepeshazi K., Groot K., Milovanovic S., Miller G., Yano T. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol. 1994;33(6):693–701. doi: 10.3109/02841869409121784. [DOI] [PubMed] [Google Scholar]
  26. Rappolee D. A., Mark D., Banda M. J., Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science. 1988 Aug 5;241(4866):708–712. doi: 10.1126/science.3041594. [DOI] [PubMed] [Google Scholar]
  27. Rozengurt E. Bombesin stimulation of mitogenesis. Specific receptors, signal transduction, and early events. Am Rev Respir Dis. 1990 Dec;142(6 Pt 2):S11–S15. doi: 10.1164/ajrccm/142.6_Pt_2.S11. [DOI] [PubMed] [Google Scholar]
  28. SALLEY J. J. Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res. 1954 Apr;33(2):253–262. doi: 10.1177/00220345540330021201. [DOI] [PubMed] [Google Scholar]
  29. Schlessinger J. Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol. 1986 Dec;103(6 Pt 1):2067–2072. doi: 10.1083/jcb.103.6.2067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shklar G., Eisenberg E., Flynn E. Immunoenhancing agents and experimental leukoplakia and carcinoma of the hamster buccal pouch. Prog Exp Tumor Res. 1979;24:269–282. doi: 10.1159/000402104. [DOI] [PubMed] [Google Scholar]
  31. Sieweke M. H., Thompson N. L., Sporn M. B., Bissell M. J. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science. 1990 Jun 29;248(4963):1656–1660. doi: 10.1126/science.2163544. [DOI] [PubMed] [Google Scholar]
  32. Szepeshazi K., Schally A. V., Cai R. Z., Radulovic S., Milovanovic S., Szoke B. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res. 1991 Nov 1;51(21):5980–5986. [PubMed] [Google Scholar]
  33. Tarnawski A., Stachura J., Durbin T., Sarfeh I. J., Gergely H. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology. 1992 Feb;102(2):695–698. doi: 10.1016/0016-5085(92)90123-g. [DOI] [PubMed] [Google Scholar]
  34. Ushiro H., Cohen S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem. 1980 Sep 25;255(18):8363–8365. [PubMed] [Google Scholar]
  35. Wilson L. K., Parsons S. J. Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src. Oncogene. 1990 Oct;5(10):1471–1480. [PubMed] [Google Scholar]
  36. Yaish P., Gazit A., Gilon C., Levitzki A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science. 1988 Nov 11;242(4880):933–935. doi: 10.1126/science.3263702. [DOI] [PubMed] [Google Scholar]
  37. Yano T., Pinski J., Groot K., Schally A. V. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res. 1992 Aug 15;52(16):4545–4547. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES